Hong Kong - Novotech, the leading Asia P
Boston, USA -
China's Biotech Evolution: In recent years, the global biotech community has witnessed
Cutting-edge advancements in Metastatic Breast Cancer Clinical Trials Introduction: Clinical trials are pivotal in pushing forward the frontiers of metastatic breast cancer trea
Dyslipidaemia, marked by abnormal blood lipids, significantly increases ischemic heart disease risk.
Arsalan Arif: Hi, everyone. I'm Arsalan Arif with Endpoints News.
John Caroll: Well, good afternoon, good morning, or wherever you may be in the world today
Background In the throes of the COVID-19 pandemic that enveloped the globe in 2021, there was an urgent and undeniable imperati
The landscape of cancer treatment has witnessed a revolutionary transformation with the advent of immune checkpoint inhibitors (ICIs), marking a paradigm shift in the approach to combating various
Explore the latest trends in immune checkpoint inhibitors clinical trials.
Orlando, Florida
Seoul, South Korea
Novotech’s Medical and Regulatory Consulting team offers full range of pre-clinical, regulatory affairs support, medical and pharmacovigilance consulting services.
Novotech relies on years of experience, in-country knowledge and real-life big data to identify and propose the best-performing sites for your study.
Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.
Novotech’s streamlined and integrated clinical trial services are delivered by a dedicated team of professionals with deep industry and therapeutic area expertise across all phases of clinical development.
Discover the power of clinical excellence with Acrostar's SMO Division, a dedicated entity operating as part of Novotech.
Delivering accurate, high-quality and timely biostatistics in clinical trials services, including statistical planning, analysis and reporting.
How virtual clinical trials can offer patient retention and cost benefits compared to traditional trials.
Accelerating patient recruitment and drug development with real world data (RWD)
Our bioanalytical services assist our customers in every stage of their molecule development.
The landscape of Oncology in Asia-Pacific Biotechnology companies are facing increased challenges around participant recruitment and rete
Our team can assist in all clinical study phases and in study designs ranging from first in human, single ascending dose, multiple ascending dose, drug-drug interaction, bioavailability/bioequivalence, food effect and special population studies.
Novotech Drug Development Consulting is a full-service global product development and strategic regulatory group, providing comprehensive “lab to launch” program development services.
Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited b
The landscape of Liver diseases in Asia-Pacific Biotechnology companies consider locations in the Asia-Pacific region, s
Providing Infectious diseases services and Vaccines CRO services Many biotechnology companies look at the Asia-Pacific region for their t
Landscape of Rare and Orphan diseases in Asia-Pacific There may be as many as 8,000 rare diseases, affecting between 6% and 8% of the wor
Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and
